Post-approval studies (Phase 4)Study completedNCT01278342
What this trial is testing
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
Who this might be right for
Acromegaly
Novartis Pharmaceuticals 70